Robert J. Feeley

TL;DR: The current literature pertaining to androgen deficiency, MetS, and ED is discussed, because the relationship of these factors is of scientific and clinical importance and a better understanding is needed of how obesity, diabetes and hypogonadism contribute to androgens deficiency and the various pathophysiologic states of vascular disease.

TL;DR: In view of the emerging evidence suggesting that androgen deficiency is a risk factor for CVD, androgen replacement therapy could potentially reduce CVD risk in hypogonadal men.

TL;DR: It is suggested that visceral obesity, a component of the metabolic syndrome, adversely affects endothelial function and testosterone levels, contributing to hypogonadism and erectile dysfunction.

TL;DR: A historical review of testosterone use in women with sexual and gynecological disorders is performed to bridge important knowledge gaps in the clinical use of testosterone inWomen with sexual health concerns and to provoke new thoughts and understanding of the multidisciplinary role ofosterone in women's overall health.

TL;DR: Social phobia and separation anxiety disorder in the offspring were accounted for by the same disorders in the parent, whereas agoraphobia and OCD in the Children at risk for panic disorder were accounts for by parental panic disorder.